nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Methotrexate—breast cancer	0.458	1	CbGbCtD
Gadopentetate dimeglumine—PGD—mammary gland—breast cancer	0.00817	0.156	CbGeAlD
Gadopentetate dimeglumine—PGD—nipple—breast cancer	0.00676	0.129	CbGeAlD
Gadopentetate dimeglumine—PGD—skin of body—breast cancer	0.00433	0.0828	CbGeAlD
Gadopentetate dimeglumine—PGD—endometrium—breast cancer	0.00408	0.0781	CbGeAlD
Gadopentetate dimeglumine—PGD—uterus—breast cancer	0.00376	0.072	CbGeAlD
Gadopentetate dimeglumine—PGD—pituitary gland—breast cancer	0.00369	0.0707	CbGeAlD
Gadopentetate dimeglumine—PGD—adipose tissue—breast cancer	0.00368	0.0704	CbGeAlD
Gadopentetate dimeglumine—PGD—female reproductive system—breast cancer	0.00338	0.0647	CbGeAlD
Gadopentetate dimeglumine—PGD—adrenal gland—breast cancer	0.0033	0.0631	CbGeAlD
Gadopentetate dimeglumine—PGD—bone marrow—breast cancer	0.00319	0.0611	CbGeAlD
Gadopentetate dimeglumine—PGD—female gonad—breast cancer	0.00307	0.0589	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A10—breast cancer	0.00305	0.0398	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—endocrine gland—breast cancer	0.00286	0.0547	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—ALDH3A1—breast cancer	0.00283	0.037	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC39A7—breast cancer	0.00252	0.033	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A5—breast cancer	0.00222	0.029	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—lymph node—breast cancer	0.00198	0.0378	CbGeAlD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC39A6—breast cancer	0.00191	0.025	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—CHST9—breast cancer	0.00168	0.022	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA3—breast cancer	0.00163	0.0212	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA4—breast cancer	0.00149	0.0194	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA2—breast cancer	0.00145	0.0189	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GPX2—breast cancer	0.00145	0.0189	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A5—breast cancer	0.00141	0.0183	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTA1—breast cancer	0.0014	0.0183	CbGpPWpGaD
Gadopentetate dimeglumine—Gadobenate Dimeglumine—ALB—breast cancer	0.00128	1	CrCbGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—GPI—breast cancer	0.00121	0.0158	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A2—breast cancer	0.00115	0.015	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—HPSE—breast cancer	0.00109	0.0142	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—HMMR—breast cancer	0.00103	0.0134	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFB2—breast cancer	0.00101	0.0131	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SQSTM1—breast cancer	0.000951	0.0124	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC5A5—breast cancer	0.000923	0.0121	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—NQO1—breast cancer	0.000891	0.0116	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—SLC2A1—breast cancer	0.000891	0.0116	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HSP90AA1—breast cancer	0.000838	0.0109	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—EGR1—breast cancer	0.000828	0.0108	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ALDOA—breast cancer	0.000755	0.00986	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTP1—breast cancer	0.000744	0.00971	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFBR2—breast cancer	0.000744	0.00971	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HMOX1—breast cancer	0.000733	0.00957	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A2—breast cancer	0.000728	0.0095	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—HGF—breast cancer	0.000683	0.00892	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—GSTM1—breast cancer	0.000683	0.00892	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—NRG1—breast cancer	0.000671	0.00876	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—ENO1—breast cancer	0.000635	0.0083	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Carbohydrate metabolism—SLC2A1—breast cancer	0.000564	0.00736	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MFGE8—breast cancer	0.000546	0.00713	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CHST9—breast cancer	0.000477	0.00623	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SYNJ2—breast cancer	0.000457	0.00597	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CCDC88C—breast cancer	0.000452	0.0059	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LGR6—breast cancer	0.000452	0.0059	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SFRP1—breast cancer	0.000431	0.00563	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NDUFS3—breast cancer	0.000425	0.00555	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SHMT1—breast cancer	0.000414	0.0054	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CHST9—breast cancer	0.0004	0.00522	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SLC2A5—breast cancer	0.000398	0.0052	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HEYL—breast cancer	0.000385	0.00502	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CUL5—breast cancer	0.000385	0.00502	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—COX11—breast cancer	0.000379	0.00495	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RSPO3—breast cancer	0.000362	0.00472	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—WNT10B—breast cancer	0.000352	0.00459	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CDA—breast cancer	0.000346	0.00452	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SHMT1—breast cancer	0.000346	0.00452	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—GPI—breast cancer	0.000343	0.00448	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A5—breast cancer	0.000333	0.00435	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLCO1B1—breast cancer	0.000333	0.00435	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—DLL4—breast cancer	0.000327	0.00427	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—APRT—breast cancer	0.000322	0.0042	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL31—breast cancer	0.000307	0.00401	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HPSE—breast cancer	0.000307	0.00401	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—LDHB—breast cancer	0.000307	0.00401	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SFRP2—breast cancer	0.000307	0.00401	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ANGPTL4—breast cancer	0.000303	0.00395	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ESRRA—breast cancer	0.000303	0.00395	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—VCP—breast cancer	0.000291	0.00381	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ABCC1—breast cancer	0.000291	0.00381	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HMMR—breast cancer	0.000291	0.00381	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPI—breast cancer	0.000287	0.00375	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HADHB—breast cancer	0.000287	0.00375	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS4X—breast cancer	0.000287	0.00374	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFBI—breast cancer	0.000287	0.00374	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—NRF2 pathway—TGFB1—breast cancer	0.000278	0.00364	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ELL—breast cancer	0.000274	0.00358	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALDH1A1—breast cancer	0.000274	0.00358	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALDH7A1—breast cancer	0.000274	0.00358	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—UMPS—breast cancer	0.000263	0.00343	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NME1—breast cancer	0.000263	0.00343	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FHL2—breast cancer	0.000263	0.00343	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PHGDH—breast cancer	0.000263	0.00343	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ADSL—breast cancer	0.000263	0.00343	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—BRIP1—breast cancer	0.000257	0.00336	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—LDHB—breast cancer	0.000257	0.00336	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HPSE—breast cancer	0.000257	0.00336	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HEY2—breast cancer	0.000257	0.00335	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS6KB2—breast cancer	0.000254	0.00331	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—IDH1—breast cancer	0.000251	0.00327	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA3—breast cancer	0.000244	0.00319	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HMMR—breast cancer	0.000244	0.00319	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ABCC1—breast cancer	0.000244	0.00319	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TLE3—breast cancer	0.00024	0.00313	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HEY1—breast cancer	0.000238	0.0031	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PPARGC1B—breast cancer	0.000236	0.00309	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—DLL1—breast cancer	0.000233	0.00304	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPL23A—breast cancer	0.000233	0.00304	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIST1H2BC—breast cancer	0.000229	0.00299	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MAP2K7—breast cancer	0.000229	0.00299	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIST1H2BK—breast cancer	0.000229	0.00299	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA4—breast cancer	0.000223	0.00291	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CA9—breast cancer	0.000223	0.00291	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA2—breast cancer	0.000218	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPX2—breast cancer	0.000218	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS7—breast cancer	0.000217	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS8—breast cancer	0.000217	0.00284	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—DKK1—breast cancer	0.000216	0.00281	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPX4—breast cancer	0.000215	0.00281	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SULT1A1—breast cancer	0.000215	0.00281	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ALDOA—breast cancer	0.000214	0.00279	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—JAG2—breast cancer	0.000211	0.00275	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTA1—breast cancer	0.00021	0.00274	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—IDH1—breast cancer	0.00021	0.00274	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—WNT1—breast cancer	0.000208	0.00271	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NAT2—breast cancer	0.000208	0.00271	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SLC2A2—breast cancer	0.000206	0.00269	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MTR—breast cancer	0.000202	0.00264	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HSPA1B—breast cancer	0.000188	0.00245	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—DPYD—breast cancer	0.000182	0.00238	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MED12—breast cancer	0.000182	0.00238	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ENO1—breast cancer	0.00018	0.00235	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ALDOA—breast cancer	0.000179	0.00234	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOA3—breast cancer	0.000174	0.00227	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A2—breast cancer	0.000173	0.00225	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGF3—breast cancer	0.00017	0.00222	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ABCG2—breast cancer	0.000169	0.00221	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CPT1A—breast cancer	0.000169	0.00221	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MTR—breast cancer	0.000169	0.00221	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—JAG1—breast cancer	0.000168	0.00219	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FASN—breast cancer	0.000168	0.00219	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PARP1—breast cancer	0.000167	0.00219	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HPGDS—breast cancer	0.000166	0.00217	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CALCA—breast cancer	0.000165	0.00216	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HBA1—breast cancer	0.000165	0.00215	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RPS6—breast cancer	0.000163	0.00213	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGF4—breast cancer	0.000162	0.00212	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CXCR4—breast cancer	0.000161	0.00211	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ACHE—breast cancer	0.000161	0.0021	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTT1—breast cancer	0.000161	0.0021	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SLC2A1—breast cancer	0.00016	0.00208	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TCF7L2—breast cancer	0.000156	0.00203	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP17A1—breast cancer	0.000152	0.00199	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS1—breast cancer	0.000151	0.00197	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ENO1—breast cancer	0.000151	0.00197	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HSP90AA1—breast cancer	0.00015	0.00196	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP2D6—breast cancer	0.000148	0.00193	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PRL—breast cancer	0.000146	0.00191	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOA2—breast cancer	0.000145	0.0019	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ADAM10—breast cancer	0.000144	0.00188	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—FASN—breast cancer	0.000141	0.00184	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—BCHE—breast cancer	0.00014	0.00183	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGF10—breast cancer	0.00014	0.00183	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC5A5—breast cancer	0.000138	0.00181	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PDGFA—breast cancer	0.000135	0.00176	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NQO1—breast cancer	0.000134	0.00175	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—SLC2A1—breast cancer	0.000134	0.00175	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFBR2—breast cancer	0.000133	0.00174	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ITPR1—breast cancer	0.000131	0.00171	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP3A4—breast cancer	0.00013	0.0017	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERBB4—breast cancer	0.00013	0.0017	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—STAT5A—breast cancer	0.00013	0.0017	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP1B1—breast cancer	0.000128	0.00167	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—SMAD4—breast cancer	0.000126	0.00165	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HSP90AA1—breast cancer	0.000126	0.00164	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HES1—breast cancer	0.000123	0.00161	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NCOR1—breast cancer	0.000122	0.0016	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOA1—breast cancer	0.000122	0.0016	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGF1—breast cancer	0.000121	0.00158	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—STK11—breast cancer	0.000121	0.00157	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP19A1—breast cancer	0.000121	0.00157	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NRG1—breast cancer	0.00012	0.00157	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—H2AFX—breast cancer	0.000119	0.00156	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERCC2—breast cancer	0.000115	0.0015	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—ERBB3—breast cancer	0.000113	0.00147	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGFR2—breast cancer	0.000112	0.00147	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—COMT—breast cancer	0.000112	0.00146	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTP1—breast cancer	0.000112	0.00146	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—HMOX1—breast cancer	0.00011	0.00144	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ITPR1—breast cancer	0.00011	0.00143	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MTHFR—breast cancer	0.000108	0.00141	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TERT—breast cancer	0.000108	0.00141	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ABCB1—breast cancer	0.000106	0.00138	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—FGFR1—breast cancer	0.000105	0.00137	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—TYMS—breast cancer	0.000104	0.00135	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—HIF1A—breast cancer	0.000103	0.00135	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—NCOR1—breast cancer	0.000102	0.00134	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—PLA2G4A—breast cancer	0.000102	0.00134	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GSTM1—breast cancer	0.000102	0.00134	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CAV1—breast cancer	9.98e-05	0.0013	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—GPX1—breast cancer	9.81e-05	0.00128	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—CYP1A1—breast cancer	9.72e-05	0.00127	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—ERCC2—breast cancer	9.64e-05	0.00126	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOS2—breast cancer	9.38e-05	0.00123	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—NOTCH1—breast cancer	9.29e-05	0.00121	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—KIT—breast cancer	9.09e-05	0.00119	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—APC—breast cancer	9.09e-05	0.00119	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—MTHFR—breast cancer	9.06e-05	0.00118	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—EGF—breast cancer	8.98e-05	0.00117	CbGpPWpGaD
Gadopentetate dimeglumine—Angiopathy—Methotrexate—breast cancer	8.73e-05	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Irinotecan—breast cancer	8.72e-05	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Mitoxantrone—breast cancer	8.72e-05	0.000212	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Methotrexate—breast cancer	8.69e-05	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Fluorouracil—breast cancer	8.69e-05	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Epirubicin—breast cancer	8.67e-05	0.000211	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Methotrexate—breast cancer	8.67e-05	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Rash—Mitoxantrone—breast cancer	8.65e-05	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Rash—Irinotecan—breast cancer	8.65e-05	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Irinotecan—breast cancer	8.64e-05	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Mitoxantrone—breast cancer	8.64e-05	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—breast cancer	8.64e-05	0.00021	CcSEcCtD
Gadopentetate dimeglumine—Chills—Methotrexate—breast cancer	8.63e-05	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Headache—Mitoxantrone—breast cancer	8.59e-05	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Headache—Irinotecan—breast cancer	8.59e-05	0.000209	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Capecitabine—breast cancer	8.58e-05	0.000208	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—BRAF—breast cancer	8.54e-05	0.00112	CbGpPWpGaD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—breast cancer	8.51e-05	0.000207	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Epirubicin—breast cancer	8.51e-05	0.000207	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Gemcitabine—breast cancer	8.49e-05	0.000206	CcSEcCtD
Gadopentetate dimeglumine—Bradycardia—Doxorubicin—breast cancer	8.48e-05	0.000206	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—breast cancer	8.45e-05	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—breast cancer	8.43e-05	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Methotrexate—breast cancer	8.43e-05	0.000205	CcSEcCtD
Gadopentetate dimeglumine—Rash—Gemcitabine—breast cancer	8.42e-05	0.000204	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Gemcitabine—breast cancer	8.42e-05	0.000204	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Epirubicin—breast cancer	8.41e-05	0.000204	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Epirubicin—breast cancer	8.39e-05	0.000204	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Methotrexate—breast cancer	8.37e-05	0.000203	CcSEcCtD
Gadopentetate dimeglumine—Headache—Gemcitabine—breast cancer	8.37e-05	0.000203	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Capecitabine—breast cancer	8.36e-05	0.000203	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—CAV1—breast cancer	8.35e-05	0.00109	CbGpPWpGaD
Gadopentetate dimeglumine—Flushing—Epirubicin—breast cancer	8.35e-05	0.000203	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Epirubicin—breast cancer	8.35e-05	0.000203	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Fluorouracil—breast cancer	8.35e-05	0.000203	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Doxorubicin—breast cancer	8.35e-05	0.000203	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—AKT2—breast cancer	8.31e-05	0.00109	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Fluorouracil—breast cancer	8.28e-05	0.000201	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Fluorouracil—breast cancer	8.27e-05	0.000201	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Capecitabine—breast cancer	8.24e-05	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—breast cancer	8.24e-05	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Paclitaxel—breast cancer	8.24e-05	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Headache—Fluorouracil—breast cancer	8.23e-05	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Doxorubicin—breast cancer	8.22e-05	0.0002	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Doxorubicin—breast cancer	8.2e-05	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Methotrexate—breast cancer	8.2e-05	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—breast cancer	8.18e-05	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Doxorubicin—breast cancer	8.18e-05	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Capecitabine—breast cancer	8.18e-05	0.000199	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—breast cancer	8.17e-05	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Epirubicin—breast cancer	8.17e-05	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Doxorubicin—breast cancer	8.16e-05	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Mitoxantrone—breast cancer	8.15e-05	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Irinotecan—breast cancer	8.15e-05	0.000198	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Epirubicin—breast cancer	8.13e-05	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Epirubicin—breast cancer	8.11e-05	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—breast cancer	8.11e-05	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—breast cancer	8.11e-05	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Methotrexate—breast cancer	8.1e-05	0.000197	CcSEcCtD
Gadopentetate dimeglumine—Chills—Epirubicin—breast cancer	8.08e-05	0.000196	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Epirubicin—breast cancer	8.04e-05	0.000195	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Doxorubicin—breast cancer	8.03e-05	0.000195	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Paclitaxel—breast cancer	8.02e-05	0.000195	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PIK3CD—breast cancer	7.99e-05	0.00104	CbGpPWpGaD
Gadopentetate dimeglumine—Decreased appetite—Capecitabine—breast cancer	7.98e-05	0.000194	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Gemcitabine—breast cancer	7.93e-05	0.000193	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Capecitabine—breast cancer	7.92e-05	0.000192	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Capecitabine—breast cancer	7.91e-05	0.000192	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Paclitaxel—breast cancer	7.91e-05	0.000192	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SERPINE1—breast cancer	7.9e-05	0.00103	CbGpPWpGaD
Gadopentetate dimeglumine—Mental disorder—Epirubicin—breast cancer	7.89e-05	0.000191	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Doxorubicin—breast cancer	7.87e-05	0.000191	CcSEcCtD
Gadopentetate dimeglumine—Pain—Capecitabine—breast cancer	7.85e-05	0.000191	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Capecitabine—breast cancer	7.85e-05	0.000191	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Epirubicin—breast cancer	7.83e-05	0.00019	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—breast cancer	7.81e-05	0.00019	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Fluorouracil—breast cancer	7.8e-05	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Doxorubicin—breast cancer	7.78e-05	0.000189	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Doxorubicin—breast cancer	7.76e-05	0.000188	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—breast cancer	7.75e-05	0.000188	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Doxorubicin—breast cancer	7.73e-05	0.000188	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Doxorubicin—breast cancer	7.73e-05	0.000188	CcSEcCtD
Gadopentetate dimeglumine—Tension—Epirubicin—breast cancer	7.69e-05	0.000187	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Epirubicin—breast cancer	7.67e-05	0.000186	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Paclitaxel—breast cancer	7.65e-05	0.000186	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CG—breast cancer	7.61e-05	0.000994	CbGpPWpGaD
Gadopentetate dimeglumine—Back pain—Epirubicin—breast cancer	7.58e-05	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Capecitabine—breast cancer	7.56e-05	0.000184	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Doxorubicin—breast cancer	7.56e-05	0.000183	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Methotrexate—breast cancer	7.55e-05	0.000183	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—NOS3—breast cancer	7.54e-05	0.000985	CbGpPWpGaD
Gadopentetate dimeglumine—Immune system disorder—Doxorubicin—breast cancer	7.52e-05	0.000183	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Capecitabine—breast cancer	7.51e-05	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Doxorubicin—breast cancer	7.51e-05	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—breast cancer	7.49e-05	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—breast cancer	7.49e-05	0.000182	CcSEcCtD
Gadopentetate dimeglumine—Chills—Doxorubicin—breast cancer	7.47e-05	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Doxorubicin—breast cancer	7.44e-05	0.000181	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Paclitaxel—breast cancer	7.4e-05	0.00018	CcSEcCtD
Gadopentetate dimeglumine—Cough—Methotrexate—breast cancer	7.31e-05	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Doxorubicin—breast cancer	7.3e-05	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Capecitabine—breast cancer	7.29e-05	0.000177	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Capecitabine—breast cancer	7.26e-05	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Capecitabine—breast cancer	7.26e-05	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Methotrexate—breast cancer	7.25e-05	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Doxorubicin—breast cancer	7.25e-05	0.000176	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Epirubicin—breast cancer	7.2e-05	0.000175	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MDM2—breast cancer	7.16e-05	0.000934	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—RAF1—breast cancer	7.13e-05	0.000931	CbGpPWpGaD
Gadopentetate dimeglumine—Arthralgia—Methotrexate—breast cancer	7.13e-05	0.000173	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Methotrexate—breast cancer	7.13e-05	0.000173	CcSEcCtD
Gadopentetate dimeglumine—Tension—Doxorubicin—breast cancer	7.11e-05	0.000173	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Paclitaxel—breast cancer	7.11e-05	0.000173	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Doxorubicin—breast cancer	7.1e-05	0.000172	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.08e-05	0.000172	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Epirubicin—breast cancer	7.07e-05	0.000172	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—ERBB2—breast cancer	7.06e-05	0.000921	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Paclitaxel—breast cancer	7.05e-05	0.000171	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Paclitaxel—breast cancer	7.05e-05	0.000171	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Epirubicin—breast cancer	7.03e-05	0.000171	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Doxorubicin—breast cancer	7.01e-05	0.00017	CcSEcCtD
Gadopentetate dimeglumine—Headache—Paclitaxel—breast cancer	7.01e-05	0.00017	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—breast cancer	6.98e-05	0.00017	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PIK3CB—breast cancer	6.96e-05	0.000909	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—MTOR—breast cancer	6.96e-05	0.000909	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—CD4—breast cancer	6.95e-05	0.000907	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—PTGS2—breast cancer	6.9e-05	0.000901	CbGpPWpGaD
Gadopentetate dimeglumine—Confusional state—Methotrexate—breast cancer	6.89e-05	0.000167	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Epirubicin—breast cancer	6.89e-05	0.000167	CcSEcCtD
Gadopentetate dimeglumine—Cough—Epirubicin—breast cancer	6.84e-05	0.000166	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Methotrexate—breast cancer	6.83e-05	0.000166	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Docetaxel—breast cancer	6.8e-05	0.000165	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Epirubicin—breast cancer	6.79e-05	0.000165	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Epirubicin—breast cancer	6.76e-05	0.000164	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Capecitabine—breast cancer	6.76e-05	0.000164	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Docetaxel—breast cancer	6.71e-05	0.000163	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Methotrexate—breast cancer	6.7e-05	0.000163	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CD—breast cancer	6.69e-05	0.000874	CbGpPWpGaD
Gadopentetate dimeglumine—Arthralgia—Epirubicin—breast cancer	6.67e-05	0.000162	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Epirubicin—breast cancer	6.67e-05	0.000162	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Doxorubicin—breast cancer	6.66e-05	0.000162	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Epirubicin—breast cancer	6.65e-05	0.000161	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Paclitaxel—breast cancer	6.64e-05	0.000161	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Methotrexate—breast cancer	6.64e-05	0.000161	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.62e-05	0.000161	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Methotrexate—breast cancer	6.61e-05	0.00016	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—ALB—breast cancer	6.6e-05	0.000862	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Capecitabine—breast cancer	6.59e-05	0.00016	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Doxorubicin—breast cancer	6.54e-05	0.000159	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CDKN1B—breast cancer	6.53e-05	0.000853	CbGpPWpGaD
Gadopentetate dimeglumine—Dry mouth—Epirubicin—breast cancer	6.52e-05	0.000158	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Methotrexate—breast cancer	6.51e-05	0.000158	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Doxorubicin—breast cancer	6.5e-05	0.000158	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Capecitabine—breast cancer	6.49e-05	0.000158	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—breast cancer	6.49e-05	0.000157	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Epirubicin—breast cancer	6.45e-05	0.000157	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Epirubicin—breast cancer	6.39e-05	0.000155	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Methotrexate—breast cancer	6.38e-05	0.000155	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Doxorubicin—breast cancer	6.37e-05	0.000155	CcSEcCtD
Gadopentetate dimeglumine—Cough—Doxorubicin—breast cancer	6.33e-05	0.000154	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—NOS3—breast cancer	6.32e-05	0.000825	CbGpPWpGaD
Gadopentetate dimeglumine—Shock—Epirubicin—breast cancer	6.29e-05	0.000153	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Doxorubicin—breast cancer	6.28e-05	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Capecitabine—breast cancer	6.28e-05	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Epirubicin—breast cancer	6.27e-05	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Docetaxel—breast cancer	6.27e-05	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Doxorubicin—breast cancer	6.26e-05	0.000152	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Epirubicin—breast cancer	6.24e-05	0.000151	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Methotrexate—breast cancer	6.23e-05	0.000151	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Epirubicin—breast cancer	6.21e-05	0.000151	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Epirubicin—breast cancer	6.18e-05	0.00015	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CTNNB1—breast cancer	6.17e-05	0.000806	CbGpPWpGaD
Gadopentetate dimeglumine—Arthralgia—Doxorubicin—breast cancer	6.17e-05	0.00015	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Doxorubicin—breast cancer	6.17e-05	0.00015	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Doxorubicin—breast cancer	6.15e-05	0.000149	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Methotrexate—breast cancer	6.14e-05	0.000149	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.13e-05	0.000149	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Epirubicin—breast cancer	6.1e-05	0.000148	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Methotrexate—breast cancer	6.09e-05	0.000148	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Methotrexate—breast cancer	6.07e-05	0.000147	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Capecitabine—breast cancer	6.07e-05	0.000147	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Doxorubicin—breast cancer	6.04e-05	0.000147	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—CDKN1A—breast cancer	6.03e-05	0.000787	CbGpPWpGaD
Gadopentetate dimeglumine—Vomiting—Docetaxel—breast cancer	6.03e-05	0.000146	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PTEN—breast cancer	6.02e-05	0.000786	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Docetaxel—breast cancer	5.98e-05	0.000145	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Epirubicin—breast cancer	5.97e-05	0.000145	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—breast cancer	5.97e-05	0.000145	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Doxorubicin—breast cancer	5.97e-05	0.000145	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Methotrexate—breast cancer	5.94e-05	0.000144	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—breast cancer	5.94e-05	0.000144	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Doxorubicin—breast cancer	5.92e-05	0.000144	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Methotrexate—breast cancer	5.9e-05	0.000143	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Methotrexate—breast cancer	5.89e-05	0.000143	CcSEcCtD
Gadopentetate dimeglumine—Pain—Methotrexate—breast cancer	5.84e-05	0.000142	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Capecitabine—breast cancer	5.84e-05	0.000142	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CB—breast cancer	5.83e-05	0.000761	CbGpPWpGaD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Epirubicin—breast cancer	5.83e-05	0.000141	CcSEcCtD
Gadopentetate dimeglumine—Shock—Doxorubicin—breast cancer	5.82e-05	0.000141	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Doxorubicin—breast cancer	5.8e-05	0.000141	CcSEcCtD
Gadopentetate dimeglumine—Rash—Capecitabine—breast cancer	5.79e-05	0.00014	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Capecitabine—breast cancer	5.78e-05	0.00014	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PTGS2—breast cancer	5.78e-05	0.000754	CbGpPWpGaD
Gadopentetate dimeglumine—Tachycardia—Doxorubicin—breast cancer	5.77e-05	0.00014	CcSEcCtD
Gadopentetate dimeglumine—Headache—Capecitabine—breast cancer	5.75e-05	0.00014	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Doxorubicin—breast cancer	5.75e-05	0.00014	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Epirubicin—breast cancer	5.74e-05	0.000139	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Doxorubicin—breast cancer	5.72e-05	0.000139	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Epirubicin—breast cancer	5.7e-05	0.000138	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Epirubicin—breast cancer	5.68e-05	0.000138	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Doxorubicin—breast cancer	5.64e-05	0.000137	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Docetaxel—breast cancer	5.63e-05	0.000137	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Methotrexate—breast cancer	5.63e-05	0.000137	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Methotrexate—breast cancer	5.59e-05	0.000136	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—SRC—breast cancer	5.58e-05	0.000729	CbGpPWpGaD
Gadopentetate dimeglumine—Decreased appetite—Epirubicin—breast cancer	5.56e-05	0.000135	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Doxorubicin—breast cancer	5.53e-05	0.000134	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Epirubicin—breast cancer	5.52e-05	0.000134	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Epirubicin—breast cancer	5.51e-05	0.000134	CcSEcCtD
Gadopentetate dimeglumine—Pain—Epirubicin—breast cancer	5.47e-05	0.000133	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Epirubicin—breast cancer	5.47e-05	0.000133	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Capecitabine—breast cancer	5.45e-05	0.000132	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Methotrexate—breast cancer	5.43e-05	0.000132	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Methotrexate—breast cancer	5.4e-05	0.000131	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Methotrexate—breast cancer	5.4e-05	0.000131	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.39e-05	0.000131	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—STAT3—breast cancer	5.38e-05	0.000703	CbGpPWpGaD
Gadopentetate dimeglumine—Paraesthesia—Doxorubicin—breast cancer	5.31e-05	0.000129	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Doxorubicin—breast cancer	5.27e-05	0.000128	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Epirubicin—breast cancer	5.27e-05	0.000128	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Doxorubicin—breast cancer	5.26e-05	0.000128	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Epirubicin—breast cancer	5.23e-05	0.000127	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Doxorubicin—breast cancer	5.14e-05	0.000125	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MAPK3—breast cancer	5.14e-05	0.000671	CbGpPWpGaD
Gadopentetate dimeglumine—Gastrointestinal disorder—Doxorubicin—breast cancer	5.11e-05	0.000124	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Doxorubicin—breast cancer	5.1e-05	0.000124	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Epirubicin—breast cancer	5.08e-05	0.000123	CcSEcCtD
Gadopentetate dimeglumine—Pain—Doxorubicin—breast cancer	5.06e-05	0.000123	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Doxorubicin—breast cancer	5.06e-05	0.000123	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Epirubicin—breast cancer	5.05e-05	0.000123	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Epirubicin—breast cancer	5.05e-05	0.000123	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PTEN—breast cancer	5.04e-05	0.000658	CbGpPWpGaD
Gadopentetate dimeglumine—Hypersensitivity—Methotrexate—breast cancer	5.03e-05	0.000122	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—MYC—breast cancer	5e-05	0.000653	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Disease—TGFB1—breast cancer	4.99e-05	0.000651	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Methotrexate—breast cancer	4.9e-05	0.000119	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—EGFR—breast cancer	4.89e-05	0.000639	CbGpPWpGaD
Gadopentetate dimeglumine—Feeling abnormal—Doxorubicin—breast cancer	4.88e-05	0.000118	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Doxorubicin—breast cancer	4.84e-05	0.000117	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Methotrexate—breast cancer	4.83e-05	0.000117	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Epirubicin—breast cancer	4.71e-05	0.000114	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Doxorubicin—breast cancer	4.7e-05	0.000114	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Doxorubicin—breast cancer	4.68e-05	0.000114	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Doxorubicin—breast cancer	4.68e-05	0.000114	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Methotrexate—breast cancer	4.68e-05	0.000113	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—KRAS—breast cancer	4.62e-05	0.000603	CbGpPWpGaD
Gadopentetate dimeglumine—Asthenia—Epirubicin—breast cancer	4.59e-05	0.000111	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Epirubicin—breast cancer	4.52e-05	0.00011	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Methotrexate—breast cancer	4.52e-05	0.00011	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Epirubicin—breast cancer	4.38e-05	0.000106	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Doxorubicin—breast cancer	4.36e-05	0.000106	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Methotrexate—breast cancer	4.34e-05	0.000105	CcSEcCtD
Gadopentetate dimeglumine—Rash—Methotrexate—breast cancer	4.31e-05	0.000105	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Methotrexate—breast cancer	4.3e-05	0.000104	CcSEcCtD
Gadopentetate dimeglumine—Headache—Methotrexate—breast cancer	4.28e-05	0.000104	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Doxorubicin—breast cancer	4.24e-05	0.000103	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—PIK3CA—breast cancer	4.24e-05	0.000554	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Epirubicin—breast cancer	4.23e-05	0.000103	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Doxorubicin—breast cancer	4.19e-05	0.000102	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Epirubicin—breast cancer	4.07e-05	9.87e-05	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Methotrexate—breast cancer	4.06e-05	9.85e-05	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Doxorubicin—breast cancer	4.05e-05	9.83e-05	CcSEcCtD
Gadopentetate dimeglumine—Rash—Epirubicin—breast cancer	4.03e-05	9.79e-05	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Epirubicin—breast cancer	4.03e-05	9.78e-05	CcSEcCtD
Gadopentetate dimeglumine—Headache—Epirubicin—breast cancer	4.01e-05	9.72e-05	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—HRAS—breast cancer	3.93e-05	0.000513	CbGpPWpGaD
Gadopentetate dimeglumine—Dizziness—Doxorubicin—breast cancer	3.91e-05	9.5e-05	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Epirubicin—breast cancer	3.8e-05	9.22e-05	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Doxorubicin—breast cancer	3.76e-05	9.13e-05	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—IL6—breast cancer	3.76e-05	0.000491	CbGpPWpGaD
Gadopentetate dimeglumine—Rash—Doxorubicin—breast cancer	3.73e-05	9.06e-05	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Doxorubicin—breast cancer	3.73e-05	9.05e-05	CcSEcCtD
Gadopentetate dimeglumine—Headache—Doxorubicin—breast cancer	3.71e-05	9e-05	CcSEcCtD
Gadopentetate dimeglumine—PGD—Metabolism—PIK3CA—breast cancer	3.55e-05	0.000464	CbGpPWpGaD
Gadopentetate dimeglumine—Nausea—Doxorubicin—breast cancer	3.51e-05	8.53e-05	CcSEcCtD
Gadopentetate dimeglumine—PGD—Disease—AKT1—breast cancer	3.47e-05	0.000453	CbGpPWpGaD
Gadopentetate dimeglumine—PGD—Metabolism—AKT1—breast cancer	2.9e-05	0.000379	CbGpPWpGaD
